U.S. Markets closed

Curis, Inc. (CRIS)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.73-0.01 (-0.57%)
At close: 4:00PM EDT
People also watch
ARQLCERSAGENARRYCYTR
Full screen
Previous Close1.74
Open1.69
Bid1.38 x 1000
Ask1.85 x 4200
Day's Range1.68 - 1.77
52 Week Range1.47 - 3.72
Volume635,279
Avg. Volume543,387
Market Cap248.91M
Beta2.48
PE Ratio (TTM)-3.53
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Curis, Inc. :CRIS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube4 days ago

    Curis, Inc. :CRIS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Curis, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Curis, Inc. – Exelixis, Inc., Infinity Pharmaceuticals, Inc., Emergent BioSolutions Inc., Bristol-Myers Squibb Company, Spectrum Pharmaceuticals, Inc., Celldex Therapeutics, Inc., Pfizer Inc., Celgene Corporation and Madrigal Pharmaceuticals, Inc. (EXEL-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 days ago

    Edited Transcript of CRIS earnings conference call or presentation 3-Aug-17 12:30pm GMT

    Q2 2017 Curis Inc Earnings Call

  • Associated Press16 days ago

    Curis reports 2Q loss

    On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 10 cents. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...